Securities
Investment Insights
Which Companies Saw Their Stock Prices Rise Despite the July Downturn—Worse Than During the IMF Crisis?
Amid concerns over a peak-out in the semiconductor sector, the July stock market saw a sharper decline than during the 1997 IMF foreign exchange crisis; however, some stocks, such as oil refining and …
Issues & Trends
[Market In] As KoreaZinc’s Stock Price Plummets… Both Sides in the Control Battle Are Left Disheartened
KoreaZinc(010130)As KoreaZinc’s stock price hit its lowest level this year, the pressure is mounting on both Chairman Choi Yoon-beom of KoreaZinc—who has been embroiled in a management control dispute…
Disclosure Plus
Oncocross Co.,Ltd. Signs Contract to Outsource 'Proteomics Analysis Services' for Digital Biobanking
#Oncocross Co.,Ltd. announced on the 30th that it had signed a contract with Omics AI Co., Ltd. to outsource proteomics analysis services as part of its Digital Biobanking (DBB) business and efforts t…
Issues & Trends
KONA I CO.,LTD. Unveils Blueprint for New Business Ventures, Expanding Beyond Local Currency to AX and the Cultural Economy
“KONA I CO.,LTD. will enhance the competitiveness of its existing business—which has grown primarily around smart cards and payment platforms—while simultaneously cultivating the local circular econom…
KRX
From '4.7 million INICS Corporation' to '1.48 million INICS Corporation'… Why Is the Securities Industry Saying, “Still, Buy”?
Following SK hynix(000660)’s second-quarter earnings announcement, securities firms have been successively lowering their target stock prices. With the stock price having fallen more than 50% from its…
Issues & Trends
PLANTYNET Co., Ltd. Pays First Interim Dividend Since Going Public… “Proactively Enhancing Shareholder Value”
IT solutions specialist PLANTYNET Co., Ltd.(075130)is accelerating efforts to enhance shareholder value by paying its first interim dividend since going public.
(Photo: PLANTYNET Co., Ltd.)
PLAN…
Issues & Trends
"KANGSTEM BIOTECH CO., LTD. Builds Commercialization Track Record… Focus on the Gap Between Corporate and Technological Value"
On the 30th, independent research firm Value Finder assessed that KANGSTEM BIOTECH CO., LTD.(217730)had confirmed, through a placebo-controlled Phase 2a clinical trial of its core pipeline candidate O…
Issues & Trends
Cracking Down on 'Rosy' Disclosures in the Pharmaceutical and Biotech Sectors… Will This Revive the Sluggish KOSDAQ?
Financial regulators have rolled up their sleeves to curb the controversy over “rosy disclosures” that are rampant in the pharmaceutical and biotech industries. On the 30th, the Financial Supervisory …
Issues & Trends
E8 Applies Simulation and AI Technologies to Predict Data Center Cooling
E8IGHT Co., Ltd(418620)(E8), a company operating a physical AI platform, announced on the 30th that it has implemented a feature to predict data center cooling environments in its physical prediction …
Issues & Trends
Aprogen Completes Submission to IRB at First Clinical Trial Site for New Drug for Osteoarthritis
Aprogen(007460)is accelerating its entry into full-scale clinical trials after completing the first phase of clinical procedures for “AP209,” a new drug candidate for degenerative arthritis currently …